Charles & Colvard

CTHR · NASDAQ

$0.00−$0.0011 (−99.91%)TodayMarket closed ·
No price history for this range.

About CTHR

Charles & Colvard Ltd. engages in the manufacture and distribution of moissanite jewels and finished jewelry featuring moissanite for sale in the worldwide jewelry market. The company is headquartered in Morrisville, North Carolina and currently employs 24 full-time employees. The company is engaged in manufactures, markets, and distributes Charles & Colvard Created Moissanite and finished jewelry featuring moissanite, including Forever One, its premium moissanite gemstone brand. The company also markets and distributes Caydia lab grown diamonds and finished jewelry featuring lab grown diamonds. The company sells moissanite jewels, loose lab grown diamonds, finished jewelry featuring moissanite, lab grown diamonds, created color gemstones, and lab grown diamonds in color at wholesale prices. Its Online Channels segment consists of e-commerce outlets including charlesandcolvard.com, moissaniteoutlet.com, charlesandcolvarddirect.com, madenetwork.com, third-party online marketplaces, drop-ship retail, and other pure-play, exclusively e-commerce outlets. Its Traditional segment consists of wholesale and retail customers, including its own Charles & Colvard Signature Showroom.

Employees
24
Headquarters
Morrisville, North Carolina
Listed
Nov 14, 1997
Sector
Consumer Discretionary
Industry
Textiles, Apparel & Luxury Goods

CTHR key statistics

Market cap
20.00K
Price-earnings ratio
—
Dividend yield
—
Average volume
28.09K
Volume
1.22K
Open price
$0.00
High today
$0.00
Low today
$0.00
52 Week high
$0.70
52 Week low
$0.002

Charles & Colvard (CTHR) at a glance

Charles & Colvard (CTHR) last traded at $0.00, with a market cap of 20.00K.

Volume so far is 1.22K shares, below the average of 28.09K shares a day.

Over the past year Charles & Colvard has ranged from $0.002 to $0.70, and now sits 0% of the way up that range.

Charles & Colvard met or beat analyst EPS estimates in 1 of the last 8 quarters. In Q3 FY24 it reported -$0.12 per share against an estimate of $0.00.

CTHR earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 1 of the last 8 quarters, by 100.0% on average.

  1. Q4 FY22: reported $0.00 per share against an estimate of -$0.102
  2. Q1 FY23: reported -$0.30 per share against an estimate of -$0.204
  3. Q2 FY23: reported -$0.30 per share against an estimate of -$0.102
  4. Q3 FY23: reported -$0.28 per share against an estimate of -$0.0306
  5. Q4 FY23: reported -$0.30 per share against an estimate of -$0.0306
  6. Q1 FY24: reported -$0.08 per share against an estimate of $0.00
  7. Q2 FY24: reported -$0.09 per share against an estimate of $0.00
  8. Q3 FY24: reported -$0.12 per share against an estimate of $0.00

CTHR news

  • Press releasePRNewswire

    Charles & Colvard Partners with VideoShops to Bring Its Lab-Grown Jewelry and Customers to the Social Commerce Network with 50,000+ Influential Sellers

  • Press releasePRNewswire

    CHARLES & COLVARD PARTNERS WITH ETHARA CAPITAL TO EXPAND LAB-GROWN DIAMOND OFFERINGS

  • Avi Kapoor

    Crude Oil Falls Over 3%; Philip Morris Earnings Top Views

  • Avi Kapoor

    Dow Jumps Over 1,000 Points; Tesla Shares Rise After Q1 Results

  • Press releasePRNewswire

    Charles & Colvard, Ltd. Announces Delisting from Nasdaq

  • Press releasePRNewswire

    Charles & Colvard, Ltd. Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q

  • 12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session

  • 12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session

Similar companies

Companies in the same industry as Charles & Colvard

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.